Is active surveillance justifiable in 3+4 cancers (prognostic grade group 2)?

Date 27 November 2016
Event European Multidisciplinary Meeting on Urological Cancers (EMUC) 2016
Session Improving active surveillance protocols in prostate cancer
Topics Prostate Cancer
Presenter L. Klotz